Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

4 big analyst picks: Amazon earns an upgrade and a coverage initiation

Published 08/06/2023, 10:36
Updated 08/06/2023, 10:36
© Reuters.

© Reuters.

Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: initiation and upgrade at Amazon.com, and upgrades at Aptive, Marsh & McLennan, and Glaukos.

InvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.

Amazon started with Overweight rating at Wells Fargo, upgraded by Edgewater

Wells Fargo initiated coverage on Amazon.com (NASDAQ:AMZN) with an Overweight rating and a price target of $159.00. Meanwhile, Edgewater Research upgraded the company to Outperform from Market Perform, as InvestingPro reported in real time.

Yesterday, The Wall Street Journal reported that Amazon is planning to launch an ad-supported tier for its Prime Video streaming service. This follows similar moves by competitors like Netflix (NASDAQ:NFLX) and Disney (NYSE:DIS), who are also exploring ad-supported options to support content spending. Additionally, Amazon is reportedly in talks with Warner Bros Discovery (NASDAQ:WBD) and Paramount (NASDAQ:PARA) to add ad-based tiers to their streaming services through Prime Video channels. Amazon, Paramount, and Warner have declined to comment on the matter, the WSJ said.

Aptive upgraded to Outperform

Wolfe Research upgraded Aptiv (NYSE:APTV) to Outperform from Peerperform with a price target of $130.00.

The firm sees several upcoming catalysts for Aptive, including a strong upward trajectory for margins, and significant potential for upside to consensus estimates. 2023 Street consensus of $4.38 EPS is consistent with the company's $4.00-$4.50 guidance, but Wolfe expects guidance to be raised on Q2/23 earnings call in August.

2 more upgrades

Evercore ISI upgraded Marsh & McLennan (NYSE:MMC) to Outperform from In Line and raised its price target to $199.00 from $195.00, expecting a 4-5% upside to consensus EPS with more visibility given a greater ability to leverage Centers of Excellence.

Piper Sandler upgraded Glaukos (NYSE:GKOS) to Overweight from Neutral and raised its price target to $80.00 from $55.00, noting it believes the Street is underestimating the ramp of both iStent Infinite and, more critically, iDose.

Jump on the biggest news for your portfolio amid a barrage of market headlines: Always be the first to know with InvestingPro.

Start your free 7-day trial now.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.